Pathophysiology of Circadian Rhythm Delayed Sleep Wake Phase Disorder
2 other identifiers
interventional
66
1 country
2
Brief Summary
The goal of this study is to understand factors that contribute to delayed sleep wake phase disorder (DSWPD). The investigators will examine whether patients with DSWPD exhibit alterations in circadian rhythms and sensitivity to light compared to healthy controls. The investigators will also test a new method of predicting circadian rhythms form a blood sample.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 2, 2024
CompletedFirst Submitted
Initial submission to the registry
June 18, 2024
CompletedFirst Posted
Study publicly available on registry
June 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
June 28, 2024
June 1, 2024
4.2 years
June 18, 2024
June 26, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Core body temperature
Body temperature measured with a pill
Continuously for 1. up to 39 and 2. 23 hours
Glucose
Blood sugar levels
Continuously for 1. up to 39 and 2. 23 hours
Subjective sleepiness
Self reported sleepiness
Every 2 hours
Psychomotor vigilance
Attention/Vigilance performance
Every 2 hours
Secondary Outcomes (2)
Skin temperature
Continuously for 1. up to 39 and 2. 23 hours
Melatonin
Hourly for 1. up to 39 hours and 2. every 20 minutes
Study Arms (1)
Assessment
EXPERIMENTALCircadian rhythms and light sensitivity
Interventions
Participants will arrive approximately 8 hours before participant's scheduled bedtime to practice ability to think testing and a 9-hour sleep study. Participants will live in the laboratory for approximately 66 hours (2.75 days). Upon awakening in the morning, participants will start a routine of up to 39 hours of wakefulness, under bedrest conditions. Saliva will be sampled frequently and blood will be drawn 3 times. Reaction time, ability to think, and subjective rating tests will be performed frequently. Participants will be provided scheduled bathroom breaks when participants will use a commode next to the bed. Outside these scheduled bathroom breaks, participants will be provided a bedpan to use to go to the bathroom. At the end of the research procedures for Visit 4 participants will be given a recovery sleep opportunity and be discharged from the lab in the morning near participant's typical waketime.
Participants will arrive in the afternoon to practice ability to think testing and a 9-hour sleep study. Participants will live in the laboratory for approximately 48 hours (2 days). Upon awakening in the morning, participants will be exposed to dim candlelight and then later in the day alternating intensities of dim and room light when we keep participants awake for up to 23 hours (We will ask participants to remain in bed seated for \~12.5 hours). Saliva will be sampled frequently. Reaction time, ability to think, and subjective rating tests will be performed frequently. Participants will then have a second 9-hour sleep opportunity.
Eligibility Criteria
You may qualify if:
- Delayed sleep wake phase disorder diagnosis
- Altitude history: currently residing at Denver altitude or higher
- BMI normal to moderately overweight
You may not qualify if:
- Recent medical condition
- Psychiatric disorder
- Sleep disorder
- Medication use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Colorado, Boulderlead
- Northwestern Universitycollaborator
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
Study Sites (2)
University of Colorado
Boulder, Colorado, 80303, United States
Northwestern University
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kenneth Wright, PhD
University of Colorado, Boulder
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 18, 2024
First Posted
June 24, 2024
Study Start
April 2, 2024
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
July 1, 2028
Last Updated
June 28, 2024
Record last verified: 2024-06